<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26022435</article-id>
      <article-id pub-id-type="pmc">4446961</article-id>
      <article-id pub-id-type="publisher-id">292</article-id>
      <article-id pub-id-type="doi">10.1186/s13000-015-0292-2</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Malignant perivascular epithelioid cell tumor (PEComa) of the femur: a case report and literature review</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lao</surname>
            <given-names>I Weng</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>Lin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Wang</surname>
            <given-names>Jian</given-names>
          </name>
          <address>
            <phone>86-21-64175590-88325</phone>
            <email>softtissuetumor@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong An Street, Shanghai, 200032 China </aff>
        <aff id="Aff2"><label/>Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong An Street, Shanghai, 200032 China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>29</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>10</volume>
      <elocation-id>54</elocation-id>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>5</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Lao et al.; licensee BioMed Central. 2015</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>We describe a case of malignant perivascular epithelial cell tumor (PEComa) arising primarily in the distal left femur of a 47-year-old male.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>The patient presented with pain accompanied by progressive swelling of his left thigh. Computed tomography (CT) scan and magnetic resonance imaging (MRI) revealed an osteolytic lesion. Curettage of the lesion was reported as a clear cell tumor with recommendation for exclusion of a metastatic clear cell carcinoma. However, thorough examinations did not find any primary site elsewhere, apart from the presence of bilateral pulmonary metastases. Evaluation of the submitted H &amp; E slides identified a malignant PEComa which was further confirmed by subsequent immunohistochemical study.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The occurrence of PEComa as a primary bone lesion is extremely rare. We present here a malignant PEComa of the distal left femur, and summarize the clinicopathological characteristics of this rare entity with literature review.</p>
        </sec>
        <sec>
          <title>Virtual slides</title>
          <p>The virtual slide (s) for this article can be found here: <ext-link ext-link-type="uri" xlink:href="http://www.diagnosticpathology.diagnomx.eu/vs/5729035221600545">http://www.diagnosticpathology.diagnomx.eu/vs/5729035221600545</ext-link>.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s13000-015-0292-2) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Perivascular epithelioid cell tumor (PEComa)</kwd>
        <kwd>Bone neoplasm</kwd>
        <kwd>Immunohistochemistry</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Perivascular epithelioid cell tumor (PEComa) represents a family of closely related entities showing both melanocytic and myoid differentiation, including angiomyolipoma, lymphangioleiomyomatosis, clear-cell &#x2018;sugar&#x2019; tumor of the lung, and neoplasms arising in a wide variety of locations including skin, soft tissue and visceral organs called PEComa not otherwise specified (PEComa-NOS) [<xref ref-type="bibr" rid="CR1">1</xref>]. PEComa manifesting as a primary bone lesion is extremely rare. To date, only 10 convincing cases of primary bone origin have been reported in the English literature [<xref ref-type="bibr" rid="CR2">2</xref>&#x2013;<xref ref-type="bibr" rid="CR8">8</xref>]. Although the majority of PEComas behave in a benign or indolent fashion, a minority of tumors exhibit aggressive behavior. The malignant variant may cause diagnostic pitfalls, particularly in interpretation of biopsy specimens. In this report, we describe a case of malignant PEComa arising primarily in the femur to broaden the anatomic spectrum of primary bone PEComas.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <sec id="Sec3">
        <title>Clinical presentation</title>
        <p>A 47-year-old male presented with a 2-year history of pain and progressive swelling of his left thigh. Computed tomography (CT) scan and magnetic resonance imaging (MRI) of the left lower limb revealed an osteolytic lesion in the distal femur (Figs.&#xA0;<xref rid="Fig1" ref-type="fig">1a and b</xref>), measuring 5.2&#x2009;&#xD7;&#x2009;3.2&#x2009;&#xD7;&#x2009;2.6&#xA0;cm in size. The lesion showed destruction of the cortex with extension into the surrounding skeletal muscle. Curettage of the lesion was performed which was initially reported as a clear cell tumor with recommendation for the exclusion of a metastatic clear cell carcinoma. No evidence of a primary tumor in any site elsewhere was identified by subsequent systematic examinations. However, CT scan of the chest revealed multiple nodules in bilateral lungs which were confirmed as metastatic by CT-guided core needle biopsy (Figs.&#xA0;<xref rid="Fig1" ref-type="fig">1c and d</xref>). The patient was treated with conservative palliative radiotherapy and systemic chemotherapy. He was alive with the disease at 3.5&#xA0;year follow up.<fig id="Fig1"><label>Fig. 1</label><caption><p>Radiology. Magnetic resonance imaging scan shows an osteolytic lesion in the distal femur (<bold>a</bold>). CT scan demonstrates cortical destruction and extension into adjacent soft tissue (<bold>b</bold>). Chest CT shows metastatic disease in bilateral lungs (<bold>c,d</bold>)</p></caption><graphic xlink:href="13000_2015_292_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec4">
        <title>Pathological findings</title>
        <p>Histologically, the tumor was composed of plump polygonal cells with abundant clear to palely eosinophilic or granular cytoplasm arranged in nests that were separated by a delicate aborizing or sinusoidal-type vasculature (Figs.&#xA0;<xref rid="Fig2" ref-type="fig">2a and b</xref>). The tumor cells showed a moderate to high degree of hypercellularity and nuclear atypia (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2c</xref>). A few multinucleated giant cells were also observed. Mitotic figures were readily encountered (5/50HPF). Occasional atypical mitotic figures were present. Areas of coagulative tumor necrosis were obvious within the tumor (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2d</xref>). Immunohistochemically, the tumor cells were strongly positive for HMB45 (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3a</xref>), PNL2, TFE3 and vimentin. Most tumor cells were also positive for alpha smooth muscle actin (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3b</xref>). There was weak staining of CD10 and CD117. CD34 staining clearly delineated the rich vascular network, highlighting the organoid or sinusoidal architecture. The tumor cells were negative for Melan-A, AE1/AE3, EMA, desmin and S100 protein.<fig id="Fig2"><label>Fig. 2</label><caption><p>Histology. Epithelioid cells arranged in nested pattern with delicate arborizing vasculature (&#xD7;100, <bold>a</bold>). Sinusoidal-type vasculature in PEComa (&#xD7;200, <bold>b</bold>). Nuclear pleomorphism with multinucleate tumor cells and mitotic activity (&#xD7;200, <bold>c</bold>). Area of necrosis present within the tumor (&#xD7;100, <bold>d</bold>)</p></caption><graphic xlink:href="13000_2015_292_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Immunohistochemistry. HMB45 (EnVision&#x2009;&#xD7;&#x2009;100, <bold>a</bold>). Alpha smooth muscle actin (EnVision&#x2009;&#xD7;&#x2009;100, <bold>b</bold>)</p></caption><graphic xlink:href="13000_2015_292_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec5" sec-type="discussion">
      <title>Discussions</title>
      <p>The first case of primary bone PEComa was described by Insabato et al. in 2002 which occurred in the tibia of a 30-year-old male [<xref ref-type="bibr" rid="CR2">2</xref>]. The presentation of PEComa as a primary bone lesion is extremely rare. Taking the current case into account, there are only 11 cases of primary bone origin. The clinical features of these 11 primary bone PEComas are summarized in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>. The site of involvement includes right tibia in 3 cases [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], right fibula in 3 cases [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], vertebral column in 2 cases (7th thoracic and 5th lumbar respectively) [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>], the sixth right rib [<xref ref-type="bibr" rid="CR5">5</xref>], left acetabulum [<xref ref-type="bibr" rid="CR8">8</xref>], and left femur (current case) in 1 case each. Like PEComas arising in other sites, primary bone PEComas also occurred in middle-aged adults with a mean age of 47&#xA0;years and median age of 39&#xA0;years (range, 26 to 93&#xA0;years) respectively. Unlike PEComas of other sites which tended to have a female predilection, primary bone PEComas were distributed approximately equally in both sexes. This disparity is possibly due to the limited number of bone PEComas being reported thus far. In accordance with the very low frequency of TSC-associated PEComas, none of the patients with bone PEComas had association with TSC.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinical features of 11 cases of primary bone PEComa</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Author/Reference</th><th>Age (y)/Sex</th><th>Site</th><th>Size (cm)</th><th>Presentation</th><th>Radiologic features</th><th>Treatment</th><th>Follow-up</th></tr></thead><tbody><tr><td>Insabato et al. [<xref ref-type="bibr" rid="CR2">2</xref>]</td><td>30/M</td><td>Right proximal tibia</td><td>2</td><td>Pain</td><td>Osteolytic with cortical destruction</td><td>Local resection</td><td>ANED, 12mo</td></tr><tr><td>Torri et al. [<xref ref-type="bibr" rid="CR5">5</xref>]</td><td>28/M</td><td>Right 6th rib</td><td>2</td><td>Pain</td><td>Osteolytic</td><td>Complete resection</td><td>ANED, not reported</td></tr><tr><td>Righi et al. [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>92/F</td><td>Right fibula</td><td>NA</td><td>NA</td><td>NA</td><td>Local resection</td><td>NA</td></tr><tr><td>Lian et al. [<xref ref-type="bibr" rid="CR3">3</xref>]</td><td>52/F</td><td>Right mid-shaft fibula</td><td>6.3</td><td>Progressive swelling</td><td>Extension through the cortex forming a soft-tissue mass</td><td>Wide excision</td><td>ANED, 3mo</td></tr><tr><td>Yamashita et al. [<xref ref-type="bibr" rid="CR6">6</xref>], case 1</td><td>35/M</td><td>7th thoracic vertebra</td><td>1.8</td><td>Bilateral leg weakness, back pain</td><td>Osteolytic, destructive enhancing lesion (MRI)</td><td>CRT</td><td>Pelvic bone metastases, AWD,12mo</td></tr><tr><td>Yamashita et al. [<xref ref-type="bibr" rid="CR6">6</xref>], case 2</td><td>39/F</td><td>Right tibia</td><td>6.5</td><td>Pain</td><td>Enhancing mass with areas of breakthrough of the cortex forming a soft-tissue mass</td><td>RT&#x2009;+&#x2009;Excision</td><td>ANED,34mo</td></tr><tr><td>Yamashita et al. [<xref ref-type="bibr" rid="CR6">6</xref>], case 3</td><td>48/F</td><td>Right distal tibia</td><td>Very small</td><td>Pain</td><td>Permeable destructive lesion with soft tissue extension (recurrent lesion)</td><td>Excisional biopsy, amputation</td><td>Recurred 3 times in 3 y, ANED, 3y</td></tr><tr><td>Kazzaz et al. [<xref ref-type="bibr" rid="CR7">7</xref>]</td><td>26/M</td><td>5th lumbar vertebra</td><td>Large</td><td>Lower back pain, left leg weakness</td><td>Destructive lesion with extra-osseous mass</td><td>Conservative</td><td>Lung metastases, ANED, not reported</td></tr><tr><td>Desy et al. [<xref ref-type="bibr" rid="CR8">8</xref>], case 1</td><td>93/F</td><td>Right distal fibula</td><td>NA</td><td>Progressive pain, swelling</td><td>Expansile lytic lesion</td><td>Local resection</td><td>ANED,2y</td></tr><tr><td>Desy et al. [<xref ref-type="bibr" rid="CR8">8</xref>], case 2</td><td>29/M</td><td>Left acetabulum</td><td>5</td><td>Progressive hip pain</td><td>Extensive lytic with soft tissue expansion</td><td>Left hemipelvectomy&#x2009;+&#x2009;temsirolimus</td><td>Lung metastases, DOD, 8mo</td></tr><tr><td>Lao et al. (our case)</td><td>47/M</td><td>Left femur</td><td>5.2</td><td>Pain, progressive swelling</td><td>Osteolytic mass, destruction of cortex forming a soft-tissue mass</td><td>Curettage&#x2009;+&#x2009;CRT</td><td>Lung metastases, AWD, 3.5y</td></tr></tbody></table><table-wrap-foot><p>
<italic>ANED</italic> indicates alive with no evidence of disease, <italic>AWD</italic> alive with disease, <italic>CRT</italic> chemo-radiotherapy, <italic>RT, radiotherapy</italic>, <italic>DOD</italic> died of disease, <italic>mo</italic> month, NA, not available <italic>y</italic> year</p></table-wrap-foot></table-wrap></p>
      <p>Clinically, patients with bone PEComas typically presented with pain. Three patients were accompanied with swelling [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], one of whom had a pathologic fracture of the distal fibula [<xref ref-type="bibr" rid="CR8">8</xref>]. One patient was accompanied with bilateral leg weakness because of cord compression [<xref ref-type="bibr" rid="CR6">6</xref>]. Radiologically, primary PEComas of bone frequently appeared as osteolytic lesions. In more aggressive cases, destruction of cortex with forming of soft tissue mass could be noted [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR8">8</xref>]. On MR imaging, the tumor was usually hypointense on T1-weighted imaging and hyperintense on T2-weighted images [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. In a biopsy-proven malignant PEComa, F-18 FDG PET demonstrated intense hypermetabolism [<xref ref-type="bibr" rid="CR9">9</xref>]. Of note, FDG PET scans were often negative in patients with benign PEComas and positive in malgiant PEComas [<xref ref-type="bibr" rid="CR10">10</xref>]. However, a benign PEComa of the lungs with extensive FDG uptake has also been described [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
      <p>Histologically, most bone PEComas were composed of epithelioid perivascular cells that exhibited characteristic nesting or organoid arrangement. Two case were composed of both epithelioid and spindle cells [<xref ref-type="bibr" rid="CR6">6</xref>]. Of 11 cases, 3 were considered to be benign which were also supported by the clinical outcome [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. One case was supposed to have malignant potential based on the invasion into the surrounding connective tissues and overexpression of cyclinD1 [<xref ref-type="bibr" rid="CR5">5</xref>]. The remaining 7 cases were recognized histologically as fully malignant. Besides permeative growth pattern, marked nuclear atypia was present in all 7 cases, necrosis was seen in 2 cases (including the current case) [<xref ref-type="bibr" rid="CR3">3</xref>], and mitotic activity was noted in 6 cases, ranging from 5/50HPF to 36/50HPF [<xref ref-type="bibr" rid="CR6">6</xref>]. Vascular invasion was identified in 2 cases [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. It is worthy to note that although most cases of malignant PEComa fulfilled the morphological criteria for malignancy proposed by Folpe et al. [<xref ref-type="bibr" rid="CR1">1</xref>], rare example existed which was not clearly malignant on histological ground, especially on biopsy specimens [<xref ref-type="bibr" rid="CR7">7</xref>]. In such instance, the malignancy was usually betrayed by its aggressive clinical behaviour.</p>
      <p>The major differential diagnosis in the current case includes metastatic clear cell carcinoma, especially of renal origin. However, immunohistochemical study ruled out this possibility as the tumor cells failed to express epithelial markers. Alveolar soft part sarcoma (ASPS), a sarcoma characterized by organoid pattern and sinusoidal-type vasculature, may cause confusion with PEComa. In particular, both tumors can express TFE3 [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. The absence of melanocytic differentiation in ASPS is helpful in the separation of these two entities. The other lesions that may enter the differential diagnoses are metastatic malignant melanoma and clear cell sarcoma. In addition to morphological differences, strong S100 protein and negative staining of myogenic markers in most melanomas and clear cell sarcomas (CCS), the presence of specific EWSR1 ATF1 fusion transcripts resulting from t (12:22) (q13; q12) in CCS are helpful features to distinguish the lesions from PEComa.</p>
      <p>It seems that malignant PEComa of bone has a tendency to develop metastatic disease. Of 7 malignant bone PEComas, four developed metastatic disease, including pelvic bone metastases in one case [<xref ref-type="bibr" rid="CR6">6</xref>], and lung metastases in other 3 cases (including the current case) [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. At present, the optimal therapy for malignant PEComa remains a challenging practice. The activation of the mTOR signaling pathway was thought mechanistically to be linked to the development of both TSC-associated and non-TSC-associated PEComa [<xref ref-type="bibr" rid="CR13">13</xref>]. Based on this pathologic mechanism, mTOR inhibitors (sirolimus/rapamycin) was applied in small number of cases and considered to be a rational molecular target for therapy in malignant PEComa [<xref ref-type="bibr" rid="CR14">14</xref>]. One patient with a malignant PEComa of the left acetabulum tried five cycles of temsirolimus with a favorable response of the suspected pulmonary metastases. However, the patient passed away eight months postoperatively despite several months of additional treatment [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
    </sec>
    <sec id="Sec6" sec-type="conclusion">
      <title>Conclusions</title>
      <p>We have described the clinicopathological and immunohistochemical features of a malignant PEComa arising primarily in the femur of an adult male. Although very rare, PEComa can present as a primary bone lesion. Clinical and pathological correlation is mandatory in arriving at the correct diagnosis.</p>
    </sec>
    <sec id="Sec7">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declared no potential conflicts of interest with publication of this case report.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>IWL drafted the report, contributed to concept. LY and JW contributed to concept and design. All authors approved the final version of the manuscript.</p>
      </fn>
    </fn-group>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Folpe</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Mentzel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lehr</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Balzer</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>SW</given-names>
            </name>
          </person-group>
          <article-title>Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologicstudy of 26 cases and review of the literature</article-title>
          <source>Am J Surg Pathol</source>
          <year>2005</year>
          <volume>29</volume>
          <issue>12</issue>
          <fpage>1558</fpage>
          <lpage>1575</lpage>
          <pub-id pub-id-type="pmid">16327428</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Insabato</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>De Rosa</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Terracciano</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Fazioli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Di Santo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rosai</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Primary monotypic epithelioid angiomyolipoma of bone</article-title>
          <source>Histopathology</source>
          <year>2002</year>
          <volume>40</volume>
          <issue>3</issue>
          <fpage>286</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2559.2002.01356.x</pub-id>
          <pub-id pub-id-type="pmid">11895495</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lian</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Chuah</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Yap</surname>
              <given-names>WM</given-names>
            </name>
          </person-group>
          <article-title>Malignant perivascular epithelioid cell tumour of the fibula: a report and a short review of bone perivascular epithelioid cell tumour</article-title>
          <source>J Clin Pathol</source>
          <year>2008</year>
          <volume>61</volume>
          <issue>10</issue>
          <fpage>127</fpage>
          <lpage>1129</lpage>
          <pub-id pub-id-type="pmid">17513508</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Righi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dimosthenous</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rosai</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>PEComa: another member of the MiT tumor family?</article-title>
          <source>Int J Surg Pathol</source>
          <year>2008</year>
          <volume>16</volume>
          <issue>1</issue>
          <fpage>16</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">18203778</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="other">Torii I, Kondo N, Takuwa T, Matsumoto S, Okumura Y, Sato A, Tanaka F, Nishigami T, Hasegawa S, Tsujimura T. Perivascular epithelioid cell tumor of the rib. Virchows Arch. 2008;452(2):697&#x2013;702.</mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamashita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>PEComa presenting in bone: clinicopathologic analysis of 6 cases and literature review</article-title>
          <source>Am J Surg Pathol</source>
          <year>2010</year>
          <volume>34</volume>
          <issue>11</issue>
          <fpage>1622</fpage>
          <lpage>1629</lpage>
          <pub-id pub-id-type="pmid">20975340</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kazzaz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Khalifa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alorjan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rezajooi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Saifuddin</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Malignant PEComa of the lumbar vertebra: a rare bone tumour</article-title>
          <source>Skeletal Radiol</source>
          <year>2012</year>
          <volume>41</volume>
          <issue>11</issue>
          <fpage>1465</fpage>
          <lpage>1468</lpage>
          <pub-id pub-id-type="pmid">22584461</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Desy</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Bernstein</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nahal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aziz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kenan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Turcotte</surname>
              <given-names>RE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary perivascular epithelioid cell neoplasm (PEComa) of bone: report of two cases and review of the literature</article-title>
          <source>Skeletal Radiol</source>
          <year>2012</year>
          <volume>41</volume>
          <issue>11</issue>
          <fpage>1469</fpage>
          <lpage>1474</lpage>
          <pub-id pub-id-type="pmid">22752420</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rakheja</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Abikhzer</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Alabed</surname>
              <given-names>YZ</given-names>
            </name>
            <name>
              <surname>Nahal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lisbona</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The appearance of osseous PEComa on F-18 FDG PET/CT</article-title>
          <source>Clin Nucl Med</source>
          <year>2012</year>
          <volume>37</volume>
          <issue>2</issue>
          <fpage>190</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="pmid">22228350</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Young</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Franz</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Nagarkatte</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Wikenheiser-Brokamp</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Galsky</surname>
              <given-names>MD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Utility of _18F_2-fluoro-2- deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis</article-title>
          <source>Chest</source>
          <year>2009</year>
          <volume>136</volume>
          <issue>3</issue>
          <fpage>926</fpage>
          <lpage>933</lpage>
          <pub-id pub-id-type="pmid">19349386</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zarbis</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Barth</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Blumstein</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Schelzig</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Pecoma of the lung: a benign tumor with extensive 18&#xA0;F-2-deoxy-D-glucose uptake</article-title>
          <source>Interact Cardiovasc Thorac Surg</source>
          <year>2007</year>
          <volume>6</volume>
          <issue>5</issue>
          <fpage>676</fpage>
          <lpage>678</lpage>
          <pub-id pub-id-type="pmid">17670735</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="other">Pang LJ, Chang B, Zou H, Qi Y, Jiang JF, Li HA, Hu WH, Chen YZ, Liu CX, Zhang WJ, Li F.Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues. Diagn Mol Pathol. 2008;17(4):245-52.</mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kenerson</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Folpe</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Takayama</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Yeung</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms</article-title>
          <source>Hum Pathol</source>
          <year>2007</year>
          <volume>38</volume>
          <issue>9</issue>
          <fpage>1361</fpage>
          <lpage>1371</lpage>
          <pub-id pub-id-type="pmid">17521703</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wagner</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Malinowska-Kolodziej</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Vena</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors</article-title>
          <source>J Clin Oncol</source>
          <year>2010</year>
          <volume>28</volume>
          <issue>5</issue>
          <fpage>835</fpage>
          <lpage>840</lpage>
          <pub-id pub-id-type="pmid">20048174</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
